319 related articles for article (PubMed ID: 25358076)
1. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
Fan Z; Zhang L
J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
[TBL] [Abstract][Full Text] [Related]
2. Using tolerance intervals for assessment of pharmaceutical quality.
Dong X; Tsong Y; Shen M; Zhong J
J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
[TBL] [Abstract][Full Text] [Related]
3. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
Tsong Y; Yang H
J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
[No Abstract] [Full Text] [Related]
4. Statistical considerations in setting product specifications.
Dong X; Tsong Y; Shen M
J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
[TBL] [Abstract][Full Text] [Related]
5. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
Darrington RT; Jiao J
J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
[TBL] [Abstract][Full Text] [Related]
6. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
Novick S; Shen Y; Yang H; Peterson J; LeBlond D; Altan S
J Biopharm Stat; 2015; 25(2):351-71. PubMed ID: 25357203
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
Tsong Y; Dong X; Shen M; Lostritto RT
J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
[TBL] [Abstract][Full Text] [Related]
8. Non-normal random effects models for immunogenicity assay cut point determination.
Zhang J; Yu B; Zhang L; Roskos L; Richman L; Yang H
J Biopharm Stat; 2015; 25(2):295-306. PubMed ID: 25356500
[TBL] [Abstract][Full Text] [Related]
9. Testing assay linearity over a pre-specified range.
Yang H; Novick SJ; LeBlond D
J Biopharm Stat; 2015; 25(2):339-50. PubMed ID: 25356663
[TBL] [Abstract][Full Text] [Related]
10. Statistical evaluation of several methods for cut-point determination of immunogenicity screening assay.
Shen M; Dong X; Tsong Y
J Biopharm Stat; 2015; 25(2):269-79. PubMed ID: 25356783
[TBL] [Abstract][Full Text] [Related]
11. Humidity-corrected Arrhenius equation: The reference condition approach.
Naveršnik K; Jurečič R
Int J Pharm; 2016 Mar; 500(1-2):360-5. PubMed ID: 26802498
[TBL] [Abstract][Full Text] [Related]
12. Analytical procedure validation and the quality by design paradigm.
Rozet E; Lebrun P; Michiels JF; Sondag P; Scherder T; Boulanger B
J Biopharm Stat; 2015; 25(2):260-8. PubMed ID: 25357001
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.
Fu M; Perlman M; Lu Q; Varga C
J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488
[TBL] [Abstract][Full Text] [Related]
14. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
Waterman KC; Carella AJ; Gumkowski MJ; Lukulay P; MacDonald BC; Roy MC; Shamblin SL
Pharm Res; 2007 Apr; 24(4):780-90. PubMed ID: 17372701
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the probability of passing the USP dissolution test.
Wang H
J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
[TBL] [Abstract][Full Text] [Related]
16. Statistical prediction of drug stability based on nonlinear parameter estimation.
King SY; Kung MS; Fung HL
J Pharm Sci; 1984 May; 73(5):657-62. PubMed ID: 6737241
[TBL] [Abstract][Full Text] [Related]
17. A quality by design approach for longitudinal quality attributes.
Lebrun P; Giacoletti K; Scherder T; Rozet E; Boulanger B
J Biopharm Stat; 2015; 25(2):247-59. PubMed ID: 25360720
[TBL] [Abstract][Full Text] [Related]
18. Using accelerated drug stability results to inform long-term studies in shelf life determination.
Faya P; Seaman JW; Stamey JD
Stat Med; 2018 Jul; 37(17):2599-2615. PubMed ID: 29766536
[TBL] [Abstract][Full Text] [Related]
19. [Shelf-life estimation of pharmaceutical products by matrixing].
Yoshioka S; Aso Y; Kojima S
Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
[TBL] [Abstract][Full Text] [Related]
20. Equivalence tests for shelf life and average drug content in stability studies.
Djira GD; Hothorn LA; Tsong Y
J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
